Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Signs and Symptoms, Respiratory
- Nebulized Fentanyl for Respiratory Symptoms in Patients With COVID-19
- Safety, Tolerability and Efficacy of S-1226 in Post-COVID-19 Subjects With Persistent Respiratory Symptoms.
- Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19:
- Anakinra for COVID-19 Respiratory Symptoms
- Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms
- In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?
- The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms
- Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program
- Effect of Intranasal Corticosteroids on Pulmonary Symptoms in Asthmatics With Nasal Congestion
- GOLD Stage I Chronic Obstructive Pulmonary Disease (COPD)
- The Effect of Montelukast Treatment in Wheezy Infants
- Respiratory Side Effects of Busulfan High Dose Chemotherapy in a Pediatric Population
- An Investigational Drug Study to Treat Respiratory Symptoms Associated With Respiratory Syncytial Virus (RSV) Bronchiolitis (0476-272)
- Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110)